Because obesity is frequently complicated by other cardiovascular risk factors, the impact of a reduction in visceral adiposity on vascular endothelial dysfunction (VED) in obese patients is difficult to determine. In the present study, we evaluated the impact of a reduction in visceral adiposity on VED in obese women. Thirty-six premenopausal obese women (BMI ≥ 25 kg/m2) without complications were enrolled in the study. VED was evaluated by determining the augmentation index (AIx) from radial artery pulse waves obtained by applanation tonometry. Changes in AIx in response to nitroglycerin-induced endothelium-independent vasodilatation (Δ AIx-NTG) and in response to salbutamol administration (Δ AIx-Salb) were determined before and after weight reduction. After a 12-week weight reduction program, the average weight loss was 7.96 ± 3.47 kg, with losses of 21.88 20.39 cm2 in visceral fat areas (p < 0.001). Pulse wave analysis combined with provocative pharmacological testing demonstrated preserved endothelium-independent vasodilation in healthy premenopausal obese women (Δ AIx-NTG: 31.36 ± 9.80% before weight reduction vs. 28.25 ± 11.21% after weight reduction, p > 0.1) and an improvement in endothelial-dependent vasodilation following weight reduction (Δ AIx-Salb: 10.03 ± 6.49% before weight reduction vs. 19.33 ± 9.28% after reduction, p < 0.001). A reduction in visceral adipose tissue was found to be most significantly related to an increase in Δ AIx-Salb (β=-0.57, p < 0.001). A reduction in visceral adiposity was significantly related to an improvement in VED. This finding suggests that reduction of visceral adiposity may be as important as the control of other major risk factors in the prevention of atherosclerosis in obese women.
- Augmentation index
- Vascular endothelial dysfunction
- Visceral adiposity